USA – BARDA opens research portal to combat COVID-19 pandemic

The Biomedical Advanced Research and Development Authority (BARDA), which is part of the US Health and Human Services Office of the Assistant Secretary for Preparedness and Response, is seeking information from stakeholders on available medical countermeasures in development. It is particularly interested in products and technologies that have progressed into or beyond non-clinical trials, have established large-scale cGMP manufacturing capability, or utilize an approved platform. This includes information regarding diagnostics, therapeutics, vaccines, and other products or technologies relevant to addressing the coronavirus outbreak.

Emergo by UL recently heard from two medical device manufacturers who were seeking our advice on ways to make their products more readily available to help address the coronavirus crisis. The first company, Through the Cords, produces an articulating endotracheal tube introducer designed to provide a low exposure risk alternative to standard intubation rescue techniques with high exposure risk profiles. The top priority when intubating COVID-19 patients is to protect the providers during this high exposure risk procedure. The company began scaling two weeks ago. The second, Shreis Scalene Sciences, has a technology that is designed, as a preventive measure, to deactivate the coronavirus and therefore decrease environmental viral load as sort of a room “disinfector.” Both products seem to nicely “fit the bill” for what BARDA is asking for…